Lexicon Pharmaceuticals Inc. (LXRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lexicon Pharmaceuticals I...

    NASDAQ: LXRX · Real-Time Price · USD
    1.09
    0.02 (1.87%)
    At close: Sep 05, 2025, 3:59 PM
    1.07
    -1.84%
    After-hours: Sep 05, 2025, 05:24 PM EDT

    Lexicon Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 31.08M 1.2M 139K 298K
    Cost of Revenue
    		 616K 85K 427K 55.05M
    Gross Profit
    		 30.46M 1.12M -288K -54.75M
    Operating Income
    		 -197.12M -171.75M -100.76M -87.09M
    Interest Income
    		 12.29M 7.73M 1.6M 134K
    Pretax Income
    		 -200.4M -177.12M -101.94M -87.76M
    Net Income
    		 -200.4M -177.12M -103.13M -88.27M
    Selling & General & Admin
    		 131.9M 113.98M 48.08M 32.34M
    Research & Development
    		 84.48M 58.89M 52.82M 55.05M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 227.58M 172.87M 100.9M 87.39M
    Interest Expense
    		 15.58M 13.1M 2.78M 802K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 228.2M 172.95M 100.9M 87.39M
    Income Tax Expense
    		 n/a n/a 1.18M 510K
    Shares Outstanding (Basic)
    		 320.03M 221.13M 165.73M 145.65M
    Shares Outstanding (Diluted)
    		 320.03M 221.13M 165.73M 145.65M
    EPS (Basic)
    		 -0.63 -0.8 -0.62 -0.61
    EPS (Diluted)
    		 -0.63 -0.8 -0.62 -0.61
    EBITDA
    		 -184.29M -163.46M -98.74M -86.66M
    EBIT
    		 -184.82M -164.02M -99.16M -86.96M
    Depreciation & Amortization
    		 534K 554K 427K 292K

    Add to Watchlist